Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
Cancer Research|June 22, 2012
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophagesKiavash Movahedi, Steve Schoonooghe, Damya Laoui, et al.Frontiers in Immunology|March 26, 2021
Immunogenicity Risk Profile of NanobodiesChloé Ackaert, Natalia Smiejkowska, Catarina Xavier, et al.Clinical Hemorheology and Microcirculation|October 11, 2005
Autologous cell based therapy for treating chronic infarct myocardiumNguyen Tran, Pierre-Yves Marie, Joseph Nloga, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2019
Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumoursPieterjan Debie, Chrystel Lafont, Michel Defrise, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2024
Efficient α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour modelHannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 7, 2009
Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological studySteven Droogmans, Bram Roosens, Bernard Cosyns, et al.Molecular Pharmaceutics|August 14, 2020
Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian CancerYana Dekempeneer, Vicky Caveliers, Maarten Ooms, et al.European Heart Journal. Cardiovascular Imaging|January 24, 2016
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaquesGezim Bala, Anneleen Blykers, Catarina Xavier, et al.Human Molecular Genetics|March 24, 2017
AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse modelAdriaan Verhelle, Nisha Nair, Inge Everaert, et al.Cardiovascular Toxicology|July 18, 2009
Dose dependency and reversibility of serotonin-induced valvular heart disease in ratsSteven Droogmans, Bram Roosens, Bernard Cosyns, et al.Pageof 13